Summary: Insulin prices continue to go up with no sign of slowing down. Stacey has a frank conversation with the folks at Eli Lilly to get their thoughts, let them answer listener questions and to talk about the recent push of state legislatures asking for more price transparency. Mike Mason, Vice President Lilly Diabetes and Dr. Sherry Martin, Vice President of Medical Development answer your questions.
